๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
NCT06057402Multiple Myeloma
Pfizer
Phase 4
80
Beijing, Guangzhou, Jinan, Hangzhou
2023-10-03
Recruiting
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
NCT05609630Juvenile Idiopathic Arthritis
AbbVie
Phase 3
90
Chongqing, Suzhou, Xi'an, Shanghai, Hangzhou
2023-10-02
Recruiting
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPฮฑ-CD47 Pathway, in Solid or Hematological Tumors
NCT05892718Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma
FBD Biologics Limited
Phase 1
80
Hangzhou
2023-10-02
Active, closed
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
NCT06157216Stage II-III Gastric Cancer
Qilu Hospital of Shandong University
Not applicable
65
Jinan, Qingdao, Yantai
2023-10-01
Recruiting
Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESD
NCT06092281Patient Compliance
Xijing Hospital of Digestive Diseases
Not applicable
500
Xi'an
2023-10-01
Recruiting
Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.
NCT06327178Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC
Nanfang Hospital, Southern Medical University
Observational
20
Guangzhou
2023-10-01
Recruiting
Development and Validation of the Modified Version of VascuQol Scale in Patients With Lower Extremity Peripheral Arterial Disease.
NCT06223217Peripheral Arterial Disease
RenJi Hospital
Observational
480
Shanghai
2023-10-01
Recruiting
Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma
NCT07097207Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital
Phase 1/2
20
Shenzhen
2023-10-01
Active, closed
Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy
NCT06066242Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
113
Tianjin
2023-10-01
Not yet open
Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT
NCT06075238Leukemia, Lymphoid
Sichuan University
Phase 2
68
Chengdu
2023-10-01
Recruiting
A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors
NCT06241898Solid Tumor
Bliss Biopharmaceutical (Hangzhou) Co., Ltd
Phase 1
300
Beijing
2023-10-01
Recruiting
Study Comparing Hemiarch Replacement and Hemiarch Plus Stent Implantation in Acute Aortic Dissection
NCT06044259Aortic Dissection
Chinese University of Hong Kong
Not applicable
72
Hong Kong
2023-10-01
Recruiting
Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer
NCT06730503Non Small Cell Lung Cancer
Shanghai Chest Hospital
Observational
250
Shanghai
2023-10-01
Recruiting
Clinical Study of Single Incision Laparoscopic Cholecystectomy in the Treatment of Patients With Acute Cholecystitis
NCT06074679Cholecystectomy, Laparoscopic
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
600
Huangshan City, Hangzhou, Huzhou, Lishui, Meicheng
2023-10-01
Recruiting
Neoadjuvant SBRT in Localized Advanced HNSCC
NCT06306846Head and Neck Squamous Carcinoma
Jiang Feng
Phase 2
81
Hangzhou
2023-10-01
Recruiting
Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma
NCT05949931Classic Hodgkin Lymphoma
Sun Yat-sen University
Phase 2
108
Guangzhou
2023-10-01
Recruiting
LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer
NCT05939063Left-sided Pancreatic Cancer
Fudan University
Not applicable
160
Shanghai
2023-10-01
Recruiting
Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO
NCT06062212Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation, Mechanical Power, Transpulmonary Mechanical Power
Beijing Chao Yang Hospital
Observational
100
Beijing
2023-10-01
Recruiting
A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases
NCT06903325Colorectal Cancer, Peritoneal Metastases
Fudan University
Observational
50
Shanghai
2023-10-01
Not yet open
Prognostic Prediction Model in Patients With Moyamoya Disease Undergoing Revascularization Surgery
NCT06051552Moyamoya Disease
Beijing Tiantan Hospital
Observational
350
Beijing
2023-10-01
Recruiting
UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.
NCT06092047CD19-positive Relapsed or Refractory B-cell Malignancies
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1
10
Hefei
2023-10-01
Recruiting
A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy
NCT06661174Bariatric Surgeries, Diabetic Nephropathy
China-Japan Friendship Hospital
Observational
100
Beijing
2023-10-01
Recruiting
The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency
NCT06427343Heart Failure, Iron Deficiency
China-Japan Friendship Hospital
Phase 4
114
Beijing
2023-10-01
Recruiting
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
NCT06100497Head and Neck Squamous Cell Carcinoma
Beijing Tongren Hospital
Phase 2
100
Beijing
2023-10-01
Recruiting
68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
NCT06277180Medullary Thyroid Cancer, Prositron Emission Tomography, Fibroblast Activation Protein Inhibitor, Surgery
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
50
Beijing
2023-10-01
Recruiting
Nutritional Intervention for Patients With Multiple Cancer Types
NCT06059560Cancer
First Hospital of China Medical University
Not applicable
1,000
Shenyang
2023-10-01
Recruiting
Real-World Study of DLBCL With Different Genetic Subtypes
NCT06026488DLBCL - Diffuse Large B Cell Lymphoma, Lymphoma
Ruijin Hospital
Observational
10,000
Shanghai
2023-10-01
Recruiting
A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL
NCT06086197Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory
Zhejiang Cancer Hospital
Phase 2
41
Hangzhou
2023-10-01
Not yet open
MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib
NCT06075225GVHD, Acute Stem Cell Transplant Complications
Sichuan University
Phase 2
62
Chengdu
2023-10-01
Not yet open
Canagliflozin With Gemcitabine in Pancreatic Carcinoma
NCT05903703Pancreatic Cancer
Zhang Xiaofeng,MD
Not applicable
20
Hangzhou
2023-10-01
Recruiting
Exploring the Novel Value of PSMA PET in Sjรถgren's Syndrome: Integrated Analysis With Established FAPI PET Imaging
NCT07324733Primary Sjรถgren Syndrome, PET
Peking Union Medical College Hospital
Not applicable
60
Beijing
2023-10-01
Recruiting
The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR
NCT06426355Diminished Ovarian Reserve
Peking University Third Hospital
Not applicable
200
Beijing
2023-10-01
Recruiting
A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
NCT06082284Multiple Myeloma, M Protein
Zhujiang Hospital
Observational
10,000
Guangzhou
2023-10-01
Recruiting
Amplification of Autologous Epidermal Cells to Repair Large Area Deep Wounds
NCT05882110Autologous Epidermal Cell Transplantation
Yicheng Ma
Not applicable
100
Shanghai
2023-10-01
Recruiting
Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer
NCT06360471Fertility Issues, Cancer
The First Affiliated Hospital with Nanjing Medical University
Observational
2,800
Nanjing
2023-10-01
Not yet open
Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST
NCT05970900Gastrointestinal Stromal Tumor of Rectum
Fujian Medical University Union Hospital
Phase 3
23
Fuzhou
2023-10-01
Recruiting
Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors
NCT06072989Advanced Solid Tumor
Shanghai East Hospital
Phase 1
24
Shanghai
2023-10
Not yet open
Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients
NCT06028633Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous Non-Small Cell Lung Cancer, Metastatic Non-squamous Non Small Cell Lung Cancer
Peking University First Hospital
Phase 2
28
Beijing
2023-10
Recruiting
Tumor Vaccines for Solid Tumors
NCT06102837Glioma, Solid Tumor
Huashan Hospital
Observational
340
Shanghai
2023-10
Not yet open
Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis
NCT05860907Breast Cancer Stage IV
Fudan University
Phase 4
384
Shijiazhuang, Zhengzhou, Changsha, Nantong, Yangzhou, Shanghai, Hangzhou, Jiaxin
2023-10
Recruiting
Invasive Intervention of Local Complications of Acute Pancreatitis
NCT06023771Acute Pancreatitis
Peking Union Medical College Hospital
Observational
100
Beijing
2023-10
Recruiting
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
NCT06076200Early-Onset Neonatal Sepsis
Shandong University
Observational
50
Jinan
2023-09-30
Recruiting
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
NCT06383520Malignant Neoplasm of Liver
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
100
Wuhan
2023-09-30
Recruiting
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
NCT06010862Gastric Cancer, Colon Cancer, Pancreas Cancer, Esophagus Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1
36
Nanchang
2023-09-30
Recruiting
Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
NCT05577091Recurrent Glioblastoma
Beijing Tiantan Hospital
Phase 1
10
Beijing
2023-09-30
Recruiting
The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block
NCT06023784Left Bundle Branch Area Pacing, Right Ventricular Pacing, Atrioventricular Block, Atrial Fibrillation
Peking Union Medical College Hospital
Not applicable
530
Beijing
2023-09-30
Recruiting
Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer ๏ผˆEBC๏ผ‰
NCT06107673Breast Cancer
Hebei Medical University Fourth Hospital
Phase 2
144
Shijiazhuang
2023-09-30
Recruiting
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
NCT05985863Acute-On-Chronic Liver Failure
Beijing 302 Hospital
Phase 1/2
150
Beijing
2023-09-30
Recruiting
New Method to Differentiate Benign and Malignant Pulmonary Nodules.
NCT06056999Pulmonary Nodules
China-Japan Friendship Hospital
Observational
150
Beijing
2023-09-29
Recruiting
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
NCT06055816Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2
40
Hangzhou
2023-09-28
Recruiting
Evaluation of Phacogoniotomy in Medically-controlled POAG
NCT06201455Glaucoma, Open-Angle, Cataract Complicated, Goniotomy
Sun Yat-sen University
Not applicable
100
Guangzhou
2023-09-28
Recruiting
Phase โ… /โ…ก Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors
NCT06088004Solid Tumor, Adult
Suzhou Abogen Biosciences Co., Ltd.
Phase 1/2
218
Beijing, Guangzhou, Nanning, Shanxi, Shenzhen
2023-09-28
Recruiting
A Phase โ…ข Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
NCT06088745Vaccine-Preventable Diseases, Herpes Zoster
Beijing Luzhu Biotechnology Co., Ltd.
Phase 3
4
Zhenjiang
2023-09-28
Recruiting
To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH
NCT05997602Langerhans Cell Histiocytosis, LCH
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2
56
Beijing, Chongqing, Guangzhou, Shenzhen, Zhengzhou, Wuhan, Chengdu, Hangzhou
2023-09-28
Recruiting
Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer
NCT05894694Advanced Colorectal Carcinoma
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase 4
320
Beijing
2023-09-27
Recruiting
9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer
NCT06079112Advanced Urothelial Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
100
Beijing
2023-09-27
Recruiting
DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs
NCT06329908Lung Cancer
Zhen-Yu Ding
Phase EARLY_PHASE1
20
Chengdu
2023-09-27
Active, closed
The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor
NCT06022250Advanced Malignant Tumor
Shanghai Junshi Bioscience Co., Ltd.
Phase 1
98
Jinan
2023-09-26
By invitation
Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
NCT07356765Schizophrenia, Negative Symptoms of Schizophrenia
Tianjin Anding Hospital
Not applicable
120
Tianjin
2023-09-26
Active, closed
A Study of ADRX-0706 in Select Advanced Solid Tumors
NCT06036121Solid Tumors, Triple Negative Breast Cancer (TNBC), Urothelial Cancer, Cervical Cancer
Adcentrx Therapeutics
Phase 1
144
Beijing, Fujian, Guangzhou, Hunan, Jinan, Shanghai, Wuhan
2023-09-26
Recruiting
Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC
NCT06165900Stereotactic Radiotherapy, Immunotherapy, Breast Cancer
Shengjing Hospital
Phase 2
136
Shenyang
2023-09-26
Recruiting
Chinese Community Sample of Hierarchical Model of Psychopathology
NCT06105970Mental Health Issue, Adverse Childhood Experience
Shanghai Mental Health Center
Observational
4,000
Shanghai
2023-09-26
Recruiting
A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
NCT06147570Nonsmall Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 2
62
Shanghai
2023-09-25
Active, closed
Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment
NCT05132790Breast Cancer
Shengjing Hospital
Not applicable
24
Shenyang
2023-09-25
Recruiting
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
NCT06114784Severe Pneumonia
First Affiliated Hospital of Zhejiang University
Observational
2,000
Hangzhou, Huzhou, Jiaxing, Lanxi, Lishui, Pinghu, Taizhou, Wenzhou
2023-09-25
Recruiting
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
NCT05968053Carotid Artery Stenosis, Glioma, Intracranial Aneurysm, Intracranial Hemorrhages
Beijing Tiantan Hospital
Observational
500
Beijing
2023-09-25
Recruiting
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells As an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
NCT06147986ST Elevation Myocardial Infarction
Ever Supreme Bio Technology Co., Ltd.
Phase 2
41
2023-09-24
Active, closed
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
NCT05911295Urothelial Carcinoma
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
2023-09-22
Recruiting
Phase 2 Trial of KN026+KN046ยฑXELOX in HER2-positive Locally Advanced GC
NCT06023758HER2-positive Locally Advanced Resectable Gastric Cancer
Peking University
Phase 2
18
Beijing
2023-09-22
Recruiting
pBFS-guided cTBS at Different Doses for Aphasia After Stroke
NCT05969548Stroke, Aphasia
Changping Laboratory
Not applicable
60
Nanyang, Zhengzhou
2023-09-22
Recruiting
RY_SW01 Cell Injection Therapy in Systemic Sclerosis
NCT06058091Systemic Sclerosis
Jiangsu Renocell Biotech Company
Phase 1/2
81
Nanjing
2023-09-22
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
NCT06079671Locally Advanced Cervical Cancer
AstraZeneca
Phase 3
800
Beijing, Changde, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou
2023-09-22
Active, closed
A Study YL201 in Patients With Selected Advanced Solid Tumors
NCT06057922Advanced Solid Tumor
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
990
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Foshan, Guangzhou
2023-09-22
Recruiting
The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure
NCT05989958Acute on Chronic Hepatic Failure, Liver Failure, Hepatitis
Hexaell Biotech Co., Ltd.
Phase 1/2
92
Beijing
2023-09-22
Active, closed
A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
NCT05987358Biliary Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
165
Beijing, Lanzhou, Tangshan, Shanghai, Tianjin
2023-09-21
Active, closed
A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD
NCT05972473Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
600
Shanghai
2023-09-21
Active, closed
Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)
NCT05822752Hepatocellular Carcinoma
AbbVie
Phase 2
130
2023-09-21
Recruiting
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
NCT05981703Advanced Solid Tumor, Solid Tumor
BeOne Medicines
Phase 1
337
Hefei, Harbin, Wuhan, Shenyang, Jining, Yantai, Shanghai, Chengdu
2023-09-21
Recruiting
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
NCT05906576Crohn Disease
Taizhou Mabtech Pharmaceutical Co.,Ltd
Phase 4
30
Beijing
2023-09-21
Recruiting
A Randomized Controlled Trial of LOT-CRT Versus conventionaL BiVP in Heart Failure Patients With NICD
NCT06061627Heart Failure, Intraventricular Block
The First Affiliated Hospital with Nanjing Medical University
Not applicable
86
Nanjing
2023-09-21
Recruiting
PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
NCT05801237Locally Advanced/Metastatic Solid Tumors
Shanghai HyaMab Biotech Co.,Ltd.
Phase 1/2
120
Shanghai
2023-09-21
Active, closed
Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)
NCT05935176Epidemic Meningitis
CanSino Biologics Inc.
Phase 4
660
Jiaozuo
2023-09-20
Recruiting
WMT for Autism Spectrum Disorder (ASD)
NCT06030752Autism Spectrum Disorder
The Second Hospital of Nanjing Medical University
Observational
80
Nanjing
2023-09-20
Recruiting
Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer
NCT06138028Metastatic Esophageal Squamous Cell Carcinoma
Qingdao Central Hospital
Phase 2/3
90
Qingdao
2023-09-20
Recruiting
Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
NCT05978648Breast Neoplasms
wang shusen
Phase 2
116
Guangzhou
2023-09-20
Recruiting
Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
NCT05872347Breast Cancer Brain Metastases
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2
52
Hefei, Guangzhou, Liuzhou, Anyang, Luoyang, Shijiazhuang, Harbin, Xiangyang
2023-09-19
Recruiting
A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors
NCT05957536HER-2 Positive Advanced Solid Tumors
D3 Bio (Wuxi) Co., Ltd
Phase 1
128
Harbin, Shanghai, Hangzhou
2023-09-19
Active, closed
Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer
NCT05994300Cervical Neoplasm, Adaptive Radiotherapy, Radiotherapy; Adverse Effect
Peking Union Medical College Hospital
Not applicable
30
Beijing
2023-09-19
Recruiting
Recurrent High Grade Glioma Treated by LITT
NCT06161610Recurrent High Grade Glioma
Beijing Tiantan Hospital
Not applicable
135
Beijing, Guangzhou, Zhengzhou, Wuhan, Changchun, Shenyang, Jinan, Shanghai
2023-09-19
Recruiting
Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage โ…ก-โ…ขB EGFR Sensitive Mutant NSCLC
NCT05987826Non-Small Cell Lung Cancer
Shanghai Zhongshan Hospital
Phase 2
40
Shanghai
2023-09-19
Recruiting
Multidisciplinary Diagnosis and Treatment of Polycystic Ovary Syndrome
NCT06047574Polycystic Ovary Syndrome
Shanghai 10th People's Hospital
Observational
3,000
Shanghai
2023-09-18
Recruiting
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy
NCT06756321Relapsed/refractory Lymphoma, Relapsed/Refractory Leukemia
Affiliated Hospital of Nantong University
Phase EARLY_PHASE1
9
Nantong
2023-09-18
Active, closed
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
NCT06047080Large B-Cell Lymphoma
Hoffmann-La Roche
Phase 3
1,130
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangdong Province Guangzhou City, Guangzhou
2023-09-18
Recruiting
Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization
NCT06228677Resistant Hypertension, Secondary Hypertension, Secondary Hypertension to Endocrine Disorders, Primary Aldosteronism
First Affiliated Hospital of Chengdu Medical College
Observational
196
Chengdu
2023-09-18
Recruiting
Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion
NCT06542653Coronary Atheroscleroses
The First Affiliated Hospital with Nanjing Medical University
Observational
258
Nanjing
2023-09-17
Recruiting
An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors
NCT06038461Neuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
40
Beijing
2023-09-15
Recruiting
Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery
NCT06286150Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
20
Guangzhou
2023-09-15
Recruiting
Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial
NCT05899582Symptomatic Chronic Middle Cerebral Artery Occlusion, Infarction, Middle Cerebral Artery
Xuanwu Hospital, Beijing
Not applicable
420
Beijing
2023-09-15
Recruiting
A Cohort Study of Uterine Malignancies
NCT05635123Cervical Cancer, Endometrial Cancer
Women's Hospital School Of Medicine Zhejiang University
Observational
6,200
Hangzhou
2023-09-15
Recruiting
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia
NCT05773729ฮฒ-thalassemia
Shanghai BDgene Co., Ltd.
Not applicable
10
Shanghai
2023-09-15
Rows per page Showing 14601–14700 of 19052
Previous 145 146 147 148 149 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=147

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.